Kayentis

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

News

The first drug from AbbVie's $8.7 billion takeover of Cerevel two years ago, Parkinson's disease therapy Juvmo, has won FDA approval.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.